Carotid Arterial Stiffness and Cardiometabolic Profiles in Women with Fibromyalgia

Background: The present study aimed to evaluate the association between FM and cardiometabolic risk factors and carotid arterial stiffness in FM patients. Methods: The cardiometabolic risk profile was defined based on the Adult Treatment Panel III panel. Carotid intimal media thickness (cIMT) and arterial stiffness were assessed using high-resolution ultrasonography. Multivariate logistic analysis was performed to estimate the association between FM and cardiometabolic risk factors. We used a general linear regression to compare the cIMT and carotid beta-index between the participants with and without FM. Pearson’s coefficient was calculated to evaluate the potential correlation between cardiometabolic risk profiles, cIMT, and arterial stiffening in FM. Results: FM participants showed a higher risk of central obesity (odds ratio [OR] = 3.21, 95% confidence interval [CI] 1.49, 6.91), high triglyceride (OR = 4.73, 95% CI 2.29, 9.79), and impaired fasting glucose (IFG) (OR = 4.27, 95% CI 2.07, 8.81) compared to the control group. The FM group exhibited higher beta-index values than the control group (p = 0.003). Although IFG and triglyceride glucose index showed a tendency to correlate with the beta-index, statistical significance was not observed. Conclusions: FM was associated with an increased risk of central obesity, high triglyceride levels, and IFG. Furthermore, advanced arterial stiffness of the carotid artery was observed in FM, which might be correlated with insulin resistance.

Working towards full eradication of lipid-driven cardiovascular risk?

Lipid-driven cardiovascular disease (CVD) risk is caused by atherogenic apolipoprotein B (apoB) particles containing low-density lipoprotein cholesterol (LDL-C), triglycerides and lipoprotein(a) [Lp(a)] and resembles a large and modifiable proportion of the total CVD risk. While a surplus of novel lipid-lowering therapies has been developed in recent years, management of lipid-driven CVD risk in the Netherlands remains suboptimal. To lower LDL‑C levels, statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibiting antibodies are the current standard of therapy. With the approval of bempedoic acid and the silencing RNA inclisiran, therapeutic options are expanding continuously. Although the use of triglyceride-lowering therapies remains a matter of debate, post hoc analyses consistently show a benefit in subsets of patients with high triglyceride or low high-density lipoprotein cholesterol levels. Pemafibrate and novel apoC-III could be efficacious options when approved for clinical use. Lp(a)-lowering therapies such as pelacarsen are under clinical investigation, offering a potent Lp(a)-lowering effect. If proven effective in reducing cardiovascular endpoints, Lp(a) lowering holds promise to be the third axis of effective lipid-lowering therapies. Using these three components of lipid-lowering treatment, the contribution of apoB-containing lipid particles to the CVD risk may be fully eradicated in the next decade.

CONVENTIONAL ECHOCARDIOGRAPHY, AORTIC ELASTICITY AND LIPID PROFILES IN OBESE VERSUS HEALTHY CHILDREN

Objectives: To compare conventional echocardiography, aortic elasticity and lipid profiles in overweight or obese children with healthy controls. Methodology: This case control study was conducted on 49 obese or overweight children aged 4 to 16 years, equally matched in age and sex of control that were normal regarding body mass index. Echocardiography and aortic elasticity findings measured for both groups and lipid profiles measured for overweight or obese children only. Data analyzed by SPSS 20 considering 0.05 as significant level. Results: Most of the echocardiography findings such as LVDS(P<0.001), LVDD(P<0.001), PWD(P<0.001), IVSS(P<0.001), LVMI(P<0.001), AS(P<0.001), AD(P<0.001) were higher significantly in obese children whereas, FS(P<0.001), FS(P<0.001), AS beta index(P<0.001) and PSEM(P<0.001) were lower compared to healthy. PWD was higher in obese (0.51±0.08 vs 0.46±0.07) compared to healthy children. Among obese or overweight children, aortic diameter in systole (AoS) (p=0.025) was higher in those with high triglyceride level. LVMI changed from those who had LDL >130. Those who had abnormal LDL (>130) had lower value of AOS (p=0.017). Systolic BP was correlated with AD (p=0.007), Diastolic BP with AS beta Index (p=0.006), AoD with AS (p=0.002), with AD (p<0.001), with AS beta Index (p=0.001) and with PSEM (P<0.001) Conclusion: Heart functions were most at risk in obese children. Amongst obese or overweight children, PWD was higher, when all other heart function were similar. LVMI was higher in children with elevated LDL level.

Level of Micro Albuminuria and Triglyceride in Type 2 Diabetes Mellitus

Experimental and clinical studies have shown a strong association between hypertriglyceridemia and diabetic nephropathy. High triglyceride variability affects the microalbuminuria

A Case Report of Familial Chylomicronemia Syndrome

Background: Diagnosis of neonatal chylomicronemia, as a very rare condition, is very difficult and usually is diagnosed when acute pancreatitis sets in. Early diagnosis can prevent the complications such as acute pancreatitis and pancreatic necrosis which are associated with the condition. Case Presentation: A 5.5 month- old female breastfed baby presented to us suffering from splenomegaly because of respiratory infection. Anemia and leukocytosis were seen in laboratory data. The result of bone marrow aspiration (BMA) performed to diagnosis was normal. Following the study, the patient had a high triglyceride, which improved with the treatment of symptoms and blood indices. Conclusion: Our case reports a rare disorder that was initially admitted with suspicion of malignancy, organomegaly, anemia and leukocytosis. In the course of hospitalization, the diagnosis of malignancy was rejected after BMA, and chylomicronemia was diagnosed and the patient's leukocytosis and high uric acid were eliminated by treatment of the disease and the patient's symptoms were improved.